• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 27VAVGJ-515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Hemorrhage/Bleeding (1888); Cardiac Tamponade (2226); Pericardial Effusion (3271); Thrombosis/Thrombus (4440)
Event Date 02/19/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Clinical information: crd_992 - valved grafts pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 27mm sjm masters series valsalva aortic valved graft was implanted.No concomitant cardiac procedures were performed during the same surgery.There were no intraprocedural adverse events reported.On (b)(6) 2023, prior to discharge, a transthoracic echocardiogram (tte) was performed which revealed the presence of fluid/pericardial effusion.On (b)(6) 2023, the patient experienced a cardiac tamponade of the pericardial sac, and another thoracotomy was performed.After the incision, a large amount of purulent content was evacuated.In the pericardial sac, there were clots noted under the sternum.In the region of the lower and lateral walls of the heart, there was 1250ml of dark blood.Patient developed anemia, therefore one unit of red blood cells was transfused.The tamponade was decompressed.Prolonged hospitalization was reported due to treatment.The patient was prescribed prophylactic antibiotic therapy.The cause of the purulent content and blood clots was believed to be the result of the cardiac tamponade and the presence of blood in the pleural cavities.The pericardial effusion and cardiac tamponade were believed to be related to the procedure and not related to the device.No additional information was provided.
 
Event Description
N/a.
 
Manufacturer Narrative
An event of presence of fluid/pericardial effusion, cardiac tamponade of pericardial sac, clots under the sternum and anemia was reported.It was also reported that there were after the incision, a large amount of purulent content was evacuated.A returned device assessment could not be performed as the device remains implants was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16584304
MDR Text Key311697100
Report Number2135147-2023-01278
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734009515
UDI-Public05414734009515
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2024
Device Model Number27VAVGJ-515
Device Catalogue Number27VAVGJ-515
Device Lot Number8491487
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/23/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization;
Patient Age39 YR
Patient SexMale
Patient Weight116 KG
Patient RaceWhite
-
-